$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
美国强生公司贝达喹啉的作用
2025-10-19 11:44:20
Check Details
美国强生公司贝达喹啉多少钱
2025-10-19 11:44:20
Check Details
美国强生公司贝达喹啉说明书
2025-10-19 11:44:20
Check Details
美国强生公司贝达喹啉效果好不好
2025-10-19 11:44:20
Check Details
美国强生公司贝达喹啉效果好吗
2025-10-19 11:44:20
Check Details
美国强生公司贝达喹啉效果怎么样
2025-10-19 11:44:20
Check Details
美国强生公司贝达喹啉用药指导
2025-10-19 11:44:20
Check Details
美国强生公司贝达喹啉用药注意事项
2025-10-19 11:44:20
Check Details
美国强生公司贝达喹啉有效果吗
2025-10-19 11:44:20
Check Details
美国强生公司贝达喹啉怎么购买
2025-10-19 11:44:20
Check Details
美国强生公司贝达喹啉怎么样
2025-10-19 11:44:20
Check Details
美国强生公司贝达喹啉治疗什么病
2025-10-19 11:44:20
Check Details
1
2
...
3619
3620
3621
3622
3623
3624
3625
...
10230
10231
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Selpercatinib: Dosing and Administration Essentials of an Oral RET Inhibitor
2
Enasidenib: A Targeted IDH2 Inhibitor for Acute Myeloid Leukemia
3
Alpelisib: From Breast Cancer to PIK3CA-Related Overgrowth Spectrum
4
Ponatinib in Chronic Myeloid Leukemia: 5-Year Results from the OPTIC Trial
5
Erdafitinib Oral Tablets: Strengths, Packaging, and Dose Adjustment
6
Capmatinib (Tabrecta): Oral Targeted Therapy for MET Exon 14 Skipping-Mutated NSCLC
7
Amivantamab Plus Lazertinib: A Chemotherapy-Free First-Line Option in EGFR-Mutated NSCLC
8
Midostaurin (Rydapt): Dosing Essentials in FLT3-Mutated AML and Systemic Mastocytosis
9
Lapatinib: An Oral Dual EGFR/HER2 TKI in HER2-Positive Breast Cancer
10
Filgotinib (Jyseleca) Overseas Guide: JAK1 Inhibitor for Rheumatoid Arthritis and Ulcerative Colitis
11
FDA Approves LISRAYA (brepocitinib): First Oral Targeted Therapy for Adults with Dermatomyositis
12
Elagolix for Endometriosis Pain: Indications and Usage Guidelines